Xcout IntelSign inSubscribe

Vetoquinol SA

0O1OPharmaceuticalsFrance

Vetoquinol S.A. is a pharmaceutical company dedicated to animal health, responsible for researching, formulating, and distributing veterinary medicines and other health-related products throughout Europe, the Americas, and the Asia Pacific. The firm offers a comprehensive range of solutions for various therapeutic areas, including pain and mobility management, inflammatory conditions, dermatology, hygiene, parasite control, udder health, infectious diseases, reproductive care, behavioral issues, internal medicine, and cardiovascular-renal disorders. These products are developed for a diverse clientele of animals, encompassing livestock such as cattle, sheep, pigs, and poultry, alongside domestic dogs. Founded in 1933, Vetoquinol S.A. maintains its headquarters in Lure, France, and operates as a subsidiary of Soparfin SCA.

Subscribe to see Vetoquinol SA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Vetoquinol SA at a glance

Vetoquinol SA is a pharmaceuticals company headquartered in France. It is publicly listed (0O1O) with a market capitalisation of $965.5M. Xcout recorded 28 job postings from Vetoquinol SA in the last 90 days, naming tools such as Power BI, Tableau.

Industry
Pharmaceuticals
Headquarters
France
Market cap
$965.5M
Employees
2,519
Ticker
0O1O
Job postings recorded (90 days)
28
Xcout AI Rank
0/100
Xcout Green Rank
0/100

Hiring at Vetoquinol SA

Xcout recorded 28 job postings from Vetoquinol SA in the last 90 days, from a hiring record Xcout has kept since June 2026.

Tools named in Vetoquinol SA's job postings

Power BITableau

The weekly hiring trend, the roles and locations behind it — see Vetoquinol SA's hiring signals →

Tech stack

VuePython

Vetoquinol SA competitors

A few of Vetoquinol SA's closest competitors — see the full list of competitors and alternatives →

ZoetisZTS · PharmaceuticalsParsippany, United States
69% matchPublicAI 15/100Green 0/100 ▼

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

Market cap$30.6B
Employees14,500
PythonAWSAzureDjangoFlask
Zoetis competitors & alternatives →

Get Vetoquinol SA's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Vetoquinol SA — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Vetoquinol SA in Xcout Intel

  • Weekly hiring history and the mix of roles behind it
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →